Cancer Genetics: Finding Meaning in Tumor and Germline Genomes (RP1611A)

Dallas, TX US
November 12, 2016

This event is a program focused on the implications of genomic testing in the cancer clinic by reviewing the various uses of molecular genetic testing (risk assessment, diagnosis and disease classification, prognosis and chemotherapy response prediction). We will discuss technologies in the areas of tumor genomic testing and germline testing by evaluating the pros, cons, and limitations of these newly available technologies. The efficacy, efficiency, and affordability of tumor genomic testing will be discussed as well as the implications of germline mutations detected through tumor genomic testing. The learner should gain a better understanding of the use of cancer genetic testing in both the tumor and the germline as it is applicable to their scope of practice. 

Target Audience

The symposium is designed for primary care providers, nurse practitioners, physician assistants, nurses, and specialists in Internal Medicine, Surgery, and Genetic Counseling.

Learning Objectives

  • Increase knowledge of the language and basic concepts of cancer genetics and ways in which a multidisciplinary approach can improve patient outcomes
  • Review currently available clinical options both for germline and tumor cancer genetic testing and implications of test results for clinical management
  • Review national guidelines for management of patients with hereditary breast, gynecologic, and/or colorectal cancer syndromes and discuss available surgical and surveillance options
  • Critically analyze available cancer genetics testing options, and make an informed and appropriate laboratory and test selection
  • Discern and consider ethical ramifications of cancer genetic testing
Course summary
Available credit: 
  • 5.75 AMA
  • 5.75 Attendance
  • 1.00 Ethics
Course opens: 
Course expires: 
Event starts: 
11/12/2016 - 7:30am CST
Event ends: 
11/12/2016 - 3:00pm CST
T. Boone Pickens Biomedical Building Auditorium
6001 Forest Park Rd.
Dallas, TX 75390
United States


Theodora Ross, M.D., Ph.D.
Professor, Department of Internal Medicine
Director, Department of Cancer Genetics
UT Southwestern Medical Center
Dallas, Texas



Accreditation and Designation Statements


The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this educational activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participatin in the activity. 

Ethics Credit:

The University of Texas Southwestern Medical Center designates the "The Patient Experience" for 1 hour in medical ethics and/or professional responsibility. 

Genetic Counselors:

The National Society of Genetic Counselors (NSGC) has authorized UT Southwestern to offer up to 0.55 CEUs or 5.58 Category 1 contact hours for the event: UT Southwestern Clinical Cancer Genetics. The American Board of Genetic Counseling (ABGC) will accept CEUs earnd at this program for the purposes of genetic counselor certification and recertification. 


UT Southwestern University Hospitals is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. 


To register:

  1. Create an account in EthosCE, online learning management system, by selecting the "create an account" link at the bottom of the page or "log-in" to your existing account.
  2. Return to this course page, select the designated fee and click on "add to cart" at the bottom of the page.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

Available Credit

  • 5.75 AMA
  • 5.75 Attendance
  • 1.00 Ethics


Please login or create an account to take this course.